LGALS3 and cancer: Additionally, the relationship between Galectin-3 and clinicopathologic factors were analyzed using the Chi-Square test and results showed that Galectin-3 expression was significantly associated with differentiation status, Lymph node status and clinical stage, but was not significantly associated with gender, age, cancer origination, volume, and CEA levels at pre-operation (Table 1).